https://stock.noler.com/us/stock/echo-therapeutics-inc https://stock.noler.com/us/stock/echo-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/echo-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/echo-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/echo-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/echo-therapeutics-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/echo-therapeutics-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/echo-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/echo-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/echo-therapeutics-inc/allocated-share-based-compensation-expense-net-of-tax https://stock.noler.com/us/stock/echo-therapeutics-inc/amended-reports-10-k https://stock.noler.com/us/stock/echo-therapeutics-inc/amended-reports-10-q https://stock.noler.com/us/stock/echo-therapeutics-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/echo-therapeutics-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/echo-therapeutics-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/echo-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/echo-therapeutics-inc/asset-impairment-charges https://stock.noler.com/us/stock/echo-therapeutics-inc/assets-held-for-sale-property-plant-and-equipment https://stock.noler.com/us/stock/echo-therapeutics-inc/assets-noncurrent https://stock.noler.com/us/stock/echo-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/echo-therapeutics-inc/capitalized-computer-software-additions https://stock.noler.com/us/stock/echo-therapeutics-inc/capitalized-computer-software-gross https://stock.noler.com/us/stock/echo-therapeutics-inc/cash https://stock.noler.com/us/stock/echo-therapeutics-inc/cash-and-due-from-banks https://stock.noler.com/us/stock/echo-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/echo-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/echo-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/echo-therapeutics-inc/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/echo-therapeutics-inc/common-stock-shares-subscribed-but-unissued https://stock.noler.com/us/stock/echo-therapeutics-inc/common-stock-shares-subscriptions https://stock.noler.com/us/stock/echo-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/echo-therapeutics-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/echo-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/echo-therapeutics-inc/current-assets https://stock.noler.com/us/stock/echo-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/echo-therapeutics-inc/damages-sought-value https://stock.noler.com/us/stock/echo-therapeutics-inc/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/echo-therapeutics-inc/debt-increase-accrued-interest https://stock.noler.com/us/stock/echo-therapeutics-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/echo-therapeutics-inc/debt-unamortized-discount https://stock.noler.com/us/stock/echo-therapeutics-inc/deconsolidation-revaluation-of-retained-investment-gain-or-loss-amount https://stock.noler.com/us/stock/echo-therapeutics-inc/deferred-costs https://stock.noler.com/us/stock/echo-therapeutics-inc/deferred-finance-costs-net https://stock.noler.com/us/stock/echo-therapeutics-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/echo-therapeutics-inc/deferred-finance-costs-ownshare-lending-arrangement-issuance-costs-accumulated-amortization-adjustment https://stock.noler.com/us/stock/echo-therapeutics-inc/deferred-finance-costs-ownshare-lending-arrangement-issuance-costs-net https://stock.noler.com/us/stock/echo-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/echo-therapeutics-inc/deferred-revenue-change https://stock.noler.com/us/stock/echo-therapeutics-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/echo-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/echo-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/echo-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/echo-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/echo-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/echo-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/echo-therapeutics-inc/deferred-tax-liabilities-tax-deferred-income https://stock.noler.com/us/stock/echo-therapeutics-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/echo-therapeutics-inc/depreciation https://stock.noler.com/us/stock/echo-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/echo-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/echo-therapeutics-inc/derivative-fair-value-of-derivative-liability https://stock.noler.com/us/stock/echo-therapeutics-inc/derivative-financial-instruments-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/echo-therapeutics-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/echo-therapeutics-inc/derivative-gain-on-derivative https://stock.noler.com/us/stock/echo-therapeutics-inc/derivative-liabilities-current https://stock.noler.com/us/stock/echo-therapeutics-inc/derivative-loss-on-derivative https://stock.noler.com/us/stock/echo-therapeutics-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/echo-therapeutics-inc/dilutive-shares https://stock.noler.com/us/stock/echo-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/echo-therapeutics-inc/embedded-derivative-gain-loss-on-embedded-derivative-net https://stock.noler.com/us/stock/echo-therapeutics-inc/eps https://stock.noler.com/us/stock/echo-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/echo-therapeutics-inc/estimated-insurance-recoveries https://stock.noler.com/us/stock/echo-therapeutics-inc/expected-amortization-expense-of-ending-present-value-of-future-insurance-profits-year-five https://stock.noler.com/us/stock/echo-therapeutics-inc/expected-amortization-expense-of-ending-present-value-of-future-insurance-profits-year-four https://stock.noler.com/us/stock/echo-therapeutics-inc/expected-amortization-expense-of-ending-present-value-of-future-insurance-profits-year-three https://stock.noler.com/us/stock/echo-therapeutics-inc/extinguishment-of-debt-gain-loss-income-tax https://stock.noler.com/us/stock/echo-therapeutics-inc/extinguishment-of-debt-gain-loss-net-of-tax https://stock.noler.com/us/stock/echo-therapeutics-inc/fair-value-assets-change-in-unrealized-gain-loss https://stock.noler.com/us/stock/echo-therapeutics-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/echo-therapeutics-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/echo-therapeutics-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/echo-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-into-level https://stock.noler.com/us/stock/echo-therapeutics-inc/fair-value-net-derivative-asset-liability-with-unobservable-inputs https://stock.noler.com/us/stock/echo-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/echo-therapeutics-inc/financing-interest-expense https://stock.noler.com/us/stock/echo-therapeutics-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/echo-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/echo-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/echo-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/echo-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/echo-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/echo-therapeutics-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/echo-therapeutics-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/echo-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/echo-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/echo-therapeutics-inc/furniture-and-fixtures-gross https://stock.noler.com/us/stock/echo-therapeutics-inc/future-amortization-expense-year-five https://stock.noler.com/us/stock/echo-therapeutics-inc/future-amortization-expense-year-four https://stock.noler.com/us/stock/echo-therapeutics-inc/future-amortization-expense-year-three https://stock.noler.com/us/stock/echo-therapeutics-inc/future-amortization-expense-year-two https://stock.noler.com/us/stock/echo-therapeutics-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/echo-therapeutics-inc/gain-loss-on-disposition-of-assets-1 https://stock.noler.com/us/stock/echo-therapeutics-inc/gain-loss-on-sale-of-capital-leases-net https://stock.noler.com/us/stock/echo-therapeutics-inc/gain-loss-on-sale-of-derivatives https://stock.noler.com/us/stock/echo-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/echo-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/echo-therapeutics-inc/income-loss-before-extraordinary-items-and-cumulative-effect-of-change-in-accounting-principle https://stock.noler.com/us/stock/echo-therapeutics-inc/income-tax https://stock.noler.com/us/stock/echo-therapeutics-inc/income-tax-examination-penalties-and-interest-accrued https://stock.noler.com/us/stock/echo-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/echo-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/echo-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/echo-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/echo-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/echo-therapeutics-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/echo-therapeutics-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/echo-therapeutics-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/echo-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/echo-therapeutics-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/echo-therapeutics-inc/increase-decrease-in-security-deposits https://stock.noler.com/us/stock/echo-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/echo-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/echo-therapeutics-inc/insider-transactions-preferred/purchases https://stock.noler.com/us/stock/echo-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/echo-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/echo-therapeutics-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/echo-therapeutics-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/echo-therapeutics-inc/interest-and-debt-expense https://stock.noler.com/us/stock/echo-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/echo-therapeutics-inc/interest-expense-other https://stock.noler.com/us/stock/echo-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/echo-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/echo-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/echo-therapeutics-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/echo-therapeutics-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/echo-therapeutics-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/echo-therapeutics-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/echo-therapeutics-inc/level-3-liability-issues https://stock.noler.com/us/stock/echo-therapeutics-inc/level-3-liability-transfers-net https://stock.noler.com/us/stock/echo-therapeutics-inc/liability-for-uncertain-tax-positions-current https://stock.noler.com/us/stock/echo-therapeutics-inc/license-and-services-revenue https://stock.noler.com/us/stock/echo-therapeutics-inc/licenses-revenue https://stock.noler.com/us/stock/echo-therapeutics-inc/litigation-reserve https://stock.noler.com/us/stock/echo-therapeutics-inc/loans-payable https://stock.noler.com/us/stock/echo-therapeutics-inc/long-term-debt-and-capital-lease-obligations https://stock.noler.com/us/stock/echo-therapeutics-inc/long-term-debt-and-capital-lease-obligations-current https://stock.noler.com/us/stock/echo-therapeutics-inc/long-term-notes-payable https://stock.noler.com/us/stock/echo-therapeutics-inc/machinery-and-equipment-gross https://stock.noler.com/us/stock/echo-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/echo-therapeutics-inc/net-income https://stock.noler.com/us/stock/echo-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/echo-therapeutics-inc/notes-payable-current https://stock.noler.com/us/stock/echo-therapeutics-inc/notes-payable-fair-value-disclosure https://stock.noler.com/us/stock/echo-therapeutics-inc/occupancy-net https://stock.noler.com/us/stock/echo-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/echo-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/echo-therapeutics-inc/operating-income https://stock.noler.com/us/stock/echo-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/echo-therapeutics-inc/operating-lease-payments-due-in-rolling-year-five https://stock.noler.com/us/stock/echo-therapeutics-inc/operating-lease-payments-due-in-rolling-year-four https://stock.noler.com/us/stock/echo-therapeutics-inc/operating-lease-payments-due-in-rolling-year-three https://stock.noler.com/us/stock/echo-therapeutics-inc/operating-lease-payments-due-in-rolling-year-two https://stock.noler.com/us/stock/echo-therapeutics-inc/operating-leases-future-minimum-payments-next-rolling-twelve-months https://stock.noler.com/us/stock/echo-therapeutics-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/echo-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/echo-therapeutics-inc/other-deferred-cost-amortization-expense https://stock.noler.com/us/stock/echo-therapeutics-inc/other-income https://stock.noler.com/us/stock/echo-therapeutics-inc/other-income-2 https://stock.noler.com/us/stock/echo-therapeutics-inc/other-noncash-expense https://stock.noler.com/us/stock/echo-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/echo-therapeutics-inc/other-nonoperating-asset-related-income https://stock.noler.com/us/stock/echo-therapeutics-inc/other-nonoperating-income https://stock.noler.com/us/stock/echo-therapeutics-inc/other-sales-revenue-net https://stock.noler.com/us/stock/echo-therapeutics-inc/paid-in-capital-income-tax-deficiency-from-share-based-compensation https://stock.noler.com/us/stock/echo-therapeutics-inc/paid-in-capital-share-based-compensation-and-exercise-of-stock-options https://stock.noler.com/us/stock/echo-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/echo-therapeutics-inc/paid-in-kind-interest https://stock.noler.com/us/stock/echo-therapeutics-inc/partners-capital-account-contributions https://stock.noler.com/us/stock/echo-therapeutics-inc/payments-for-legal-settlements https://stock.noler.com/us/stock/echo-therapeutics-inc/payments-for-software https://stock.noler.com/us/stock/echo-therapeutics-inc/payments-of-debt-extinguishment-costs https://stock.noler.com/us/stock/echo-therapeutics-inc/payments-of-financing-costs https://stock.noler.com/us/stock/echo-therapeutics-inc/payments-to-acquire-machinery-and-equipment https://stock.noler.com/us/stock/echo-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/echo-therapeutics-inc/preferred-stock-accretion-of-redemption-discount https://stock.noler.com/us/stock/echo-therapeutics-inc/preferred-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/echo-therapeutics-inc/preferred-stock-dividends-income-statement-impact https://stock.noler.com/us/stock/echo-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/echo-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/echo-therapeutics-inc/preferred-stock-shares-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/echo-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/echo-therapeutics-inc/proceeds-from-collection-of-loans-receivable https://stock.noler.com/us/stock/echo-therapeutics-inc/proceeds-from-contributions-from-parent https://stock.noler.com/us/stock/echo-therapeutics-inc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/echo-therapeutics-inc/proceeds-from-hedge-financing-activities https://stock.noler.com/us/stock/echo-therapeutics-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/echo-therapeutics-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/echo-therapeutics-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/echo-therapeutics-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/echo-therapeutics-inc/proceeds-from-other-debt https://stock.noler.com/us/stock/echo-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/echo-therapeutics-inc/proceeds-from-secured-notes-payable https://stock.noler.com/us/stock/echo-therapeutics-inc/proceeds-from-short-term-debt https://stock.noler.com/us/stock/echo-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/echo-therapeutics-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/echo-therapeutics-inc/property-plant-and-equipment-fair-value-disclosure https://stock.noler.com/us/stock/echo-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/echo-therapeutics-inc/property-plant-and-equipment-other https://stock.noler.com/us/stock/echo-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/echo-therapeutics-inc/public-float https://stock.noler.com/us/stock/echo-therapeutics-inc/repayments-of-debt https://stock.noler.com/us/stock/echo-therapeutics-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/echo-therapeutics-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/echo-therapeutics-inc/repayments-of-short-term-debt https://stock.noler.com/us/stock/echo-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/echo-therapeutics-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/echo-therapeutics-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/echo-therapeutics-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/echo-therapeutics-inc/restricted-cash-and-investments https://stock.noler.com/us/stock/echo-therapeutics-inc/restricted-stock-expense https://stock.noler.com/us/stock/echo-therapeutics-inc/restricted-stock-shares-issued-net-of-shares-for-tax-withholdings https://stock.noler.com/us/stock/echo-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/echo-therapeutics-inc/revenue https://stock.noler.com/us/stock/echo-therapeutics-inc/revenue-from-grants https://stock.noler.com/us/stock/echo-therapeutics-inc/sale-of-stock-consideration-received-per-transaction https://stock.noler.com/us/stock/echo-therapeutics-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/echo-therapeutics-inc/sales-revenue-services-gross https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-10-k https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-10-q https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-10ksb https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-10ksb40 https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-10qsb https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-25 https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-25-nse https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-425 https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-8-k https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-ars https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-certnas https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-ct-order https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-def-14a https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-defa14a https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-defc14a https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-defs14a https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-dfan14a https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-prec14a https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-prer14a https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-pres14a https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-prrn14a https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-regdex https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-revoked https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-s-4 https://stock.noler.com/us/stock/echo-therapeutics-inc/sec-filings-sb-2 https://stock.noler.com/us/stock/echo-therapeutics-inc/secondary-offerings-form-424b1 https://stock.noler.com/us/stock/echo-therapeutics-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/echo-therapeutics-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/echo-therapeutics-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/echo-therapeutics-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/echo-therapeutics-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/echo-therapeutics-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/echo-therapeutics-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/echo-therapeutics-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/echo-therapeutics-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/echo-therapeutics-inc/secured-debt https://stock.noler.com/us/stock/echo-therapeutics-inc/settlement-liabilities-current https://stock.noler.com/us/stock/echo-therapeutics-inc/sga-expense https://stock.noler.com/us/stock/echo-therapeutics-inc/share-based-goods-and-nonemployee-services-transaction-quantity-of-securities-issued https://stock.noler.com/us/stock/echo-therapeutics-inc/share-price https://stock.noler.com/us/stock/echo-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/echo-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/echo-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-compensation-cost https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-payments https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-non-option-equity-instruments-forfeitures https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-non-option-equity-instruments-outstanding-number https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-rsu-change https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-rsu-grants-in-period-intrinsic-value https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-compensation-cash-received-from-exercise-of-stock-options https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-issued-shares-issued-shares-issued-for-cash https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-issued-shares-issued-shares-restricted-stock-award-gross https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-forfeitures https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/echo-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/echo-therapeutics-inc/tax-credit-carryforward-amount https://stock.noler.com/us/stock/echo-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/echo-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/echo-therapeutics-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/echo-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/echo-therapeutics-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/echo-therapeutics-inc/total-assets https://stock.noler.com/us/stock/echo-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/echo-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/echo-therapeutics-inc/valuation-allowances-and-reserves-change https://stock.noler.com/us/stock/echo-therapeutics-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/echo-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted